Copeptin After Arginine Infusion in Polyuria-Polydipsia Syndrome

the purpose of the study is to investigate whether arginine infusion is a new tool to differentiate patients with diabetes insipidus, primary polydipsia and healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Diabetes Insipidus Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pituitary Diseases Polyuria-polydipsia Syndrome Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Basel

Basel, Canton of Basel-City, 4031, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age over 18 years
No medication except hormonal contraception

Exclusion criteria

Evidence of any acute illness
Subjects refusing or unable to give written informed consent
Pregnancy
Any evidence of disordered drinking habits and diuresis

Treatment and study plan

Primary outcomes

Discriminative value of copeptin after arginine infusion in the differential diagnosis of polyuria-polydipsia syndrome.

Time frame: up to 120 minutes after the Arginine infusion.

Sponsors and collaborators

Lead sponsor

University Hospital, Basel, Switzerland

Other

Registry information

Official study title

Copeptin After Arginine Infusion for the Differential Diagnosis of the Polyuria-Polydipsia Syndrome ''The CARGO-Study''

Important dates

Study start: 2013
Primary completion: 2017
Study completion: 2017
First posted: Jun 17, 2013
Registry last updated: Jul 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed